<DOC>
	<DOCNO>NCT00950781</DOCNO>
	<brief_summary>This ancillary study Protocol 16997 examine stress hormone level woman menopausal symptom . This ancillary project collect additional data 45 subject enrol Protocol 16997 ( subject enrol Protocol 16997 far ) . This study protocol differs main protocol ( 16997 ) include ACTH ( Hormone ) Stimulation Test ass function stress response subject entry exit . Subjects undergo ACTH test ancillary protocol morning complete 24-hour urine collection Protocol 16997 . The ACTH ( Hormone ) Stimulation Test do main protocol 16997 . During ACTH test IV place subject arm , 25mL blood drawn -30 minute 6mL blood drawn -15 minute 0 minute respectively . Following , 0.25mg ACTH inject intravenous 60 second , final 12mL blood drawn 60 minute later . That , total 50mL blood drawn test serum blood hormone level subject ACTH ( Hormone ) Stimulation Test . The 24 hour cortisol data collect main protocol 16997 use study analysis . When subject consent Protocol 16997 , also consent ancillary study . In addition consent visit , subject two study specific visit ( entry exit ) ancillary study . The PI schedule specific visit study conjunction schedule Protocol 16997 . There collaboration site ancillary study .</brief_summary>
	<brief_title>Cortisol Levels Menopausal Symptoms - Ancillary ( Addendum ) Study Protocol 16997</brief_title>
	<detailed_description />
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>1 . Women menopausal VMS bothersome enough warrant treatment ; 2 . Minimum 7 hot flash per day ( average ) ; 3 . Age limit : woman age 4070 least one miss menstrual cycle undergone spontaneous menopause , woman age medically induced menopause , woman age oophorectomy ; 4 . Informed write consent ; 5 . Ability follow treatment protocol . Exclusion Criteria ( cohort ) 1 . Concomitant illness reasonable likelihood limit survival le one year ; 2 . Current substance abuse ( alcohol drug ) ; 3 . Pregnancy know , suspect plan next year . Exclusion Criteria ( TA intervention ) 1 . Other concomitant menopause treatment ; 2 . Participating acupuncture treatment formal psychological stress management program within last year ; 3 . Participating another treatment VMS , unless willing stop 4 week advance participation ; 4 . HIV infection , chronic active hepatitis bloodborne illness .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Cortisol</keyword>
	<keyword>ACTH</keyword>
</DOC>